6 FDA Decisions To Watch in Q2 2026
The second quarter is looking very busy for the FDA, which in April is expected to make a handful of very important decisions. One of them is for a rare disease with unmet needs, while the other, for the treatment of melanoma, can be a sign of how things can change in the institution after … Read more